Irritable Bowel Syndrome (IBS) Market Report

Global and China Irritable Bowel Syndrome (IBS) Industry Market Research Report (2017-2028)

  • POSTDATE：Dec 05, 2022
  • PAGES：236
  • REPORT CODE：GMM1437742
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Irritable Bowel Syndrome (IBS) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Sebela Pharmaceuticals

    • IM HealthScience

    • McNeil Consumer Healthcare

    • Allergan

    • Takeda

    • Valeant Pharmaceuticals

    • Sucampo Pharmaceuticals

    • Astellas Pharmaceuticals

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • IBS-D Drug

    • IBS-C Drug

    • Other

    Application:

    • Other

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Irritable Bowel Syndrome (IBS) Industry Overview

      • 1.1.1 Irritable Bowel Syndrome (IBS) Market Scope and Market Segments

      • 1.1.2 Irritable Bowel Syndrome (IBS) Industry Characteristics

      • 1.1.3 Global and China Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Irritable Bowel Syndrome (IBS) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 IBS-D Drug

      • 1.2.2 IBS-C Drug

      • 1.2.3 Other

    • 1.3 Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Other

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Irritable Bowel Syndrome (IBS) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Irritable Bowel Syndrome (IBS) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Irritable Bowel Syndrome (IBS) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Irritable Bowel Syndrome (IBS) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Irritable Bowel Syndrome (IBS) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Irritable Bowel Syndrome (IBS) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Irritable Bowel Syndrome (IBS) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Irritable Bowel Syndrome (IBS) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Irritable Bowel Syndrome (IBS) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Irritable Bowel Syndrome (IBS) Industry PEST Analysis

    • 2.3 Irritable Bowel Syndrome (IBS) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Irritable Bowel Syndrome (IBS) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Irritable Bowel Syndrome (IBS) Industry

    Chapter 3 Global and China Irritable Bowel Syndrome (IBS) Market, by Manufacturer

    • 3.1 Global and China Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Irritable Bowel Syndrome (IBS) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Irritable Bowel Syndrome (IBS) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Irritable Bowel Syndrome (IBS) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Irritable Bowel Syndrome (IBS) Market Top 3 Players

    Chapter 4 Global and China Irritable Bowel Syndrome (IBS) Market, by Type (2017-2028)

    • 4.1 Irritable Bowel Syndrome (IBS) Market Trend, by Type

    • 4.2 Global Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Irritable Bowel Syndrome (IBS) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Irritable Bowel Syndrome (IBS) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Irritable Bowel Syndrome (IBS) Price Trend, by Type (2017-2028)

    • 4.3 China Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Irritable Bowel Syndrome (IBS) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Irritable Bowel Syndrome (IBS) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Irritable Bowel Syndrome (IBS) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Irritable Bowel Syndrome (IBS) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Irritable Bowel Syndrome (IBS) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Irritable Bowel Syndrome (IBS) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Irritable Bowel Syndrome (IBS) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Irritable Bowel Syndrome (IBS) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Irritable Bowel Syndrome (IBS) Market Analysis

    • 7.1 North America Irritable Bowel Syndrome (IBS) Market, by Type

    • 7.2 North America Irritable Bowel Syndrome (IBS) Market, by Application

    • 7.3 North America Irritable Bowel Syndrome (IBS) Market Analysis and Forecast, by Country

      • 7.3.1 United States Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Irritable Bowel Syndrome (IBS) Market Analysis

    • 8.1 Europe Irritable Bowel Syndrome (IBS) Market, by Type

    • 8.2 Europe Irritable Bowel Syndrome (IBS) Market, by Application

    • 8.3 Europe Irritable Bowel Syndrome (IBS) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Irritable Bowel Syndrome (IBS) Market Analysis

    • 9.1 APAC Irritable Bowel Syndrome (IBS) Market, by Type

    • 9.2 APAC Irritable Bowel Syndrome (IBS) Market, by Application

    • 9.3 APAC Irritable Bowel Syndrome (IBS) Market Analysis and Forecast, by Country

      • 9.3.1 China Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Market Analysis

    • 10.1 Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Market, by Type

    • 10.2 Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Market, by Application

    • 10.3 Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Irritable Bowel Syndrome (IBS) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Irritable Bowel Syndrome (IBS) Company Profiles

      • 11.1 Sebela Pharmaceuticals

        • 11.1.1 Sebela Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Profiles, Application and Specification

        • 11.1.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 IM HealthScience

        • 11.2.1 IM HealthScience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 IM HealthScience Irritable Bowel Syndrome (IBS) Product Profiles, Application and Specification

        • 11.2.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 McNeil Consumer Healthcare

        • 11.3.1 McNeil Consumer Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Product Profiles, Application and Specification

        • 11.3.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Allergan

        • 11.4.1 Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Allergan Irritable Bowel Syndrome (IBS) Product Profiles, Application and Specification

        • 11.4.3 Allergan Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Takeda

        • 11.5.1 Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Takeda Irritable Bowel Syndrome (IBS) Product Profiles, Application and Specification

        • 11.5.3 Takeda Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Valeant Pharmaceuticals

        • 11.6.1 Valeant Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Profiles, Application and Specification

        • 11.6.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Sucampo Pharmaceuticals

        • 11.7.1 Sucampo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Profiles, Application and Specification

        • 11.7.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Astellas Pharmaceuticals

        • 11.8.1 Astellas Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Profiles, Application and Specification

        • 11.8.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Irritable Bowel Syndrome (IBS) Industry Investment Prospect and Risk Assessment

    • 12.1 Irritable Bowel Syndrome (IBS) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Irritable Bowel Syndrome (IBS) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Production Value and Growth Rate (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Production Value and Growth Rate (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-D Drug (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of IBS-C Drug (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Other (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Market Size and Growth Rate of Other (2017-2028)

    • Figure North America Irritable Bowel Syndrome (IBS) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Irritable Bowel Syndrome (IBS) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Irritable Bowel Syndrome (IBS) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Irritable Bowel Syndrome (IBS) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Irritable Bowel Syndrome (IBS) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Irritable Bowel Syndrome (IBS) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Irritable Bowel Syndrome (IBS) Market Share, by Manufacturer in 2021

    • Figure Global and China Irritable Bowel Syndrome (IBS) Market Share, by Manufacturer in 2022

    • Table Global Irritable Bowel Syndrome (IBS) Sales Volume, by Type (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Sales Volume Share, by Type (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Sales Volume Share, by Type (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Sales Value, by Type (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Sales Value Share, by Type (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Price Trend, by Type (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Sales Volume, by Type (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Sales Volume Share, by Type (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Sales Volume Share, by Type (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Sales Value, by Type (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Sales Value Share, by Type (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Price Trend, by Type (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Sales Volume, by Application (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Sales Volume Share, by Application (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Sales Volume Share, by Application (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Sales Value, by Application (2017-2028)

    • Table Global Irritable Bowel Syndrome (IBS) Sales Value Share, by Application (2017-2028)

    • Figure Global Irritable Bowel Syndrome (IBS) Sales Value Share, by Application (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Sales Volume, by Application (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Sales Volume Share, by Application (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Sales Volume Share, by Application (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Sales Value, by Application (2017-2028)

    • Table China Irritable Bowel Syndrome (IBS) Sales Value Share, by Application (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Sales Value Share, by Application (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Production, Import, Consumption and Export (2017-2022)

    • Table North America Irritable Bowel Syndrome (IBS) Sales Volume, by Type (2017-2028)

    • Table North America Irritable Bowel Syndrome (IBS) Sales Volume Share, by Type (2017-2028)

    • Figure North America Irritable Bowel Syndrome (IBS) Sales Volume Share, by Type (2017-2028)

    • Table North America Irritable Bowel Syndrome (IBS) Sales Volume, by Application (2017-2028)

    • Table North America Irritable Bowel Syndrome (IBS) Sales Volume Share, by Application (2017-2028)

    • Figure North America Irritable Bowel Syndrome (IBS) Sales Volume Share, by Application (2017-2028)

    • Figure United States Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Table Europe Irritable Bowel Syndrome (IBS) Sales Volume, by Type (2017-2028)

    • Table Europe Irritable Bowel Syndrome (IBS) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Irritable Bowel Syndrome (IBS) Sales Volume Share, by Type (2017-2028)

    • Table Europe Irritable Bowel Syndrome (IBS) Sales Volume, by Application (2017-2028)

    • Table Europe Irritable Bowel Syndrome (IBS) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Irritable Bowel Syndrome (IBS) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure UK Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure France Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure France Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Table APAC Irritable Bowel Syndrome (IBS) Sales Volume, by Type (2017-2028)

    • Table APAC Irritable Bowel Syndrome (IBS) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Irritable Bowel Syndrome (IBS) Sales Volume Share, by Type (2017-2028)

    • Table APAC Irritable Bowel Syndrome (IBS) Sales Volume, by Application (2017-2028)

    • Table APAC Irritable Bowel Syndrome (IBS) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Irritable Bowel Syndrome (IBS) Sales Volume Share, by Application (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure China Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure India Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure India Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Irritable Bowel Syndrome (IBS) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Irritable Bowel Syndrome (IBS) Sales Value and Growth Rate (2017-2028)

    • Table Sebela Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sebela Pharmaceuticals Product Profiles, Application and Specification

    • Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table IM HealthScience Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table IM HealthScience Product Profiles, Application and Specification

    • Table IM HealthScience Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table McNeil Consumer Healthcare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table McNeil Consumer Healthcare Product Profiles, Application and Specification

    • Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Allergan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Allergan Product Profiles, Application and Specification

    • Table Allergan Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takeda Product Profiles, Application and Specification

    • Table Takeda Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Valeant Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Valeant Pharmaceuticals Product Profiles, Application and Specification

    • Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sucampo Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sucampo Pharmaceuticals Product Profiles, Application and Specification

    • Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Astellas Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Astellas Pharmaceuticals Product Profiles, Application and Specification

    • Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US